Intensity Therapeutics Inc.

Last updated September 27, 2026

Organization details

Legal name
Intensity Therapeutics Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
INTS
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001567264

Board of directors

Chief executives

Lewis H. Bender · President and CEO
Since June 2023

Board connections

1 of this board's directors also sit on 1 other board.

Network of Intensity Therapeutics Inc.'s board connections Pasithea Therapeutics Corp. Pasithea Therapeutics... Emer Leahy Emer Leahy Intensity Therapeutics Inc...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jun 30, 2026 Talamo Joseph Officer (Chief Financial Officer) Grant or award +1,093 $3.49 $3,809
Jun 30, 2026 Wesolowski John M Officer (Principal Accounting Officer) Grant or award +3,688 $3.49 $12,853
Mar 26, 2026 Lewis H. Bender Director, Officer (President and CEO) Grant or award +37,749 $6.11 $230,646
Dec 31, 2025 Wesolowski John M Officer (Principal Accounting Officer) Grant or award +8,918 $0.26 $2,319
Dec 31, 2025 Talamo Joseph Officer (Chief Financial Officer) Grant or award +14,482 $0.26 $3,765
Jun 30, 2025 Wesolowski John M Officer (Principal Accounting Officer) Grant or award +69,745 $0.26 $18,134
Jun 30, 2025 Talamo Joseph Officer (Chief Financial Officer) Grant or award +14,179 $0.26 $3,687
Jun 5, 2024 Wesolowski John M Officer (Principal Accounting Officer) Option exercise +1,000 $4.00 $4,000

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.